Why NYSE:WST qualifies as a quality stock.

Quality investors are looking for the best of the best. Companies which are growing steadily and consistently, but are also in excellent financial condition. We will have a look here to see if WEST PHARMACEUTICAL SERVICES (NYSE:WST) is suited for quality investing. Investors should of couse do their own research, but we spotted WEST PHARMACEUTICAL SERVICES showing up in our Caviar Cruise quality screen, so it may be worth spending some more time on it.

Why NYSE:WST may be interesting for quality investors.

• The 5-year revenue growth of WEST PHARMACEUTICAL SERVICES has been remarkable, with 12.54% increase. This showcases the company's strong performance in driving revenue growth and indicates its competitiveness within the market.
• With a robust ROIC excluding cash and goodwill at 26.01%, WEST PHARMACEUTICAL SERVICES showcases its effective allocation of capital and operational excellence. This metric signifies the company's ability to generate attractive returns and supports its long-term financial performance.
• With a Debt/Free Cash Flow Ratio of 0.52, WEST PHARMACEUTICAL SERVICES exhibits solid financial health and responsible debt management practices. This ratio indicates the company's ability to generate ample free cash flow to meet its debt obligations and pursue growth opportunities.
• WEST PHARMACEUTICAL SERVICES exhibits impressive Profit Quality (5-year) with a 79.91% ratio, reflecting its consistent ability to generate high-quality profits. This metric underscores the company's strong financial performance and commitment to delivering sustainable earnings.
• WEST PHARMACEUTICAL SERVICES has experienced impressive EBIT growth over the past 5 years, with 25.76% increase. This reflects the company's effective operational performance and highlights its potential for long-term financial success.
• WEST PHARMACEUTICAL SERVICES has achieved impressive EBIT 5-year growth, surpassing its Revenue 5-year growth. This indicates the company's ability to improve its profitability and operational efficiency, highlighting its strong financial performance.

Fundamental analysis of NYSE:WST

ChartMill assigns a proprietary Fundamental Rating to each stock. The score is computed daily by evaluating various fundamental indicators and properties. The score ranges from 0 to 10.

We assign a fundamental rating of 6 out of 10 to WST. WST was compared to 63 industry peers in the Life Sciences Tools & Services industry. WST has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. WST has a decent growth rate and is not valued too expensively.

Our latest full fundamental report of WST contains the most current fundamental analsysis.

More quality stocks can be found in our Caviar Cruise screen.

Keep in mind

This article should in no way be interpreted as advice in any way. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.